Singular Genomics Systems Long Term Debt

Singular Genomics Systems (OMIC) currently reports a long-term debt of $45M as of September 2024. That compares with $69M in the prior-year period — down 35.0% year over year. Use the charts on this page to explore Singular Genomics Systems's long-term debt history and peer comparisons.

Singular Genomics Systems's long-term debt decreased from $69M to $45M — a 35.0% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Singular Genomics Systems reported $45M in long-term debt as of September 2024. That compares with $69M in the prior-year period — down 35.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $45M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Singular Genomics Systems, and consider following OMIC for alerts when major investors trade the stock.

Singular Genomics Systems is classified in the Healthcare sector. On long-term debt, it currently shows $45M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OMIC with unrelated industries.